US Representative

Pat Ryan Authored & Sponsored Legislation

Session

Co-Sponsor of Legislation

US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2444

Introduced
3/27/25  
Refer
3/27/25  
Report Pass
4/8/25  
Promoting Resilient Supply Chains Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2531

Introduced
4/1/25  
Workplace Violence Prevention for Health Care and Social Service Workers Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2538

Introduced
4/1/25  
CARE Act of 2025 Comprehensive Alternative Response for Emergencies Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2550

Introduced
4/1/25  
Protect America's Workforce Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2591

Introduced
4/2/25  
Refer
4/2/25  
Refer
4/3/25  
Mental Health in Aviation Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2671

Introduced
4/7/25  
Tax Fairness for Workers Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2692

Introduced
4/7/25  
No Tax Breaks for Union Busting (NTBUB) Act
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB27

Introduced
1/3/25  
Refer
1/3/25  
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl ActThis bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.Under the bill, offenses involving fentanyl-related substances are triggered by the same quantity thresholds and subject to the same penalties as offenses involving fentanyl analogues (e.g., offenses involving 100 grams or more trigger a 10-year mandatory minimum prison term).Additionally, the bill establishes a new, alternative registration process for certain schedule I research.The bill also makes several other changes to registration requirements for conducting research with controlled substances, includingpermitting a single registration for related research sites in certain circumstances,waiving the requirement for a new inspection in certain situations, andallowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.Finally, the bill expresses the sense that Congress agrees with the interpretation of Controlled Substances Act in United States v. McCray, a 2018 case decided by the U.S. District Court for the Western District of New York. In that case, the court held that butyryl fentanyl, a controlled substance, can be considered an analogue of fentanyl even though, under the Controlled Substances Act, the term controlled substance analogue specifically excludes a controlled substance.
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2711

Introduced
4/8/25  
Invest to Protect Act of 2025
US

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB2743

Introduced
4/8/25  
Raise the Wage Act of 2025